BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38803127)

  • 21. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing medical abortion through telemedicine in Colombia: a qualitative study.
    Piay-Fernández N; Stenbacka E; Jaramillo MC; Guerrero G; Solano Rodríguez AA; Montenegro P; Moreno DC; Cleeve A
    Sex Reprod Health Matters; 2023 Dec; 31(4):2236780. PubMed ID: 37565788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland.
    Aiken ARA; Digol I; Trussell J; Gomperts R
    BMJ; 2017 May; 357():j2011. PubMed ID: 28512085
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cases of mycoses in Culex pipiens L. mosquitoes in Azerbaijan, Uzbekistan and in Southern Ukraine].
    Kupriianova ES; Aksenova AS
    Parazitologiia; 1973; 7(4):374-6. PubMed ID: 4272381
    [No Abstract]   [Full Text] [Related]  

  • 26. Self-administered versus provider-administered medical abortion.
    Gambir K; Kim C; Necastro KA; Ganatra B; Ngo TD
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013181. PubMed ID: 32150279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
    Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
    Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.
    Boydell N; Reynolds-Wright JJ; Cameron ST; Harden J
    BJOG; 2021 Oct; 128(11):1752-1761. PubMed ID: 34138505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using telemedicine to improve early medical abortion at home (UTAH): a randomised controlled trial to compare telemedicine with in-person consultation for early medical abortion.
    Reynolds-Wright JJ; Norrie J; Cameron ST
    BMJ Open; 2023 Sep; 13(9):e073630. PubMed ID: 37709327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provision of medical abortion using telemedicine in Brazil.
    Gomperts R; van der Vleuten K; Jelinska K; da Costa CV; Gemzell-Danielsson K; Kleiverda G
    Contraception; 2014 Feb; 89(2):129-33. PubMed ID: 24314910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
    Anger HA; Raymond EG
    Contraception; 2023 Aug; 124():110055. PubMed ID: 37088124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
    Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
    Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Anger HA; Raymond EG; Grant M; Haskell S; Boraas C; Tocce K; Banks J; Coplon L; Shochet T; Platais I; Winikoff B
    Contraception; 2021 Dec; 104(6):659-665. PubMed ID: 34329607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial.
    Iyengar K; Paul M; Iyengar SD; Klingberg-Allvin M; Essén B; Bring J; Soni S; Gemzell-Danielsson K
    Lancet Glob Health; 2015 Sep; 3(9):e537-45. PubMed ID: 26275330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
    Reynolds-Wright JJ; Johnstone A; McCabe K; Evans E; Cameron S
    BMJ Sex Reprod Health; 2022 Jul; 48(3):185-192. PubMed ID: 34711647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
    Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
    Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion.
    Kapp N; Mao B; Menzel J; Eckersberger E; Saphonn V; Rathavy T; Pearson E
    BMJ Sex Reprod Health; 2023 Oct; 49(4):300-307. PubMed ID: 36894309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of telephone follow-up after medical abortion.
    Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
    Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication Abortion With Pharmacist Dispensing of Mifepristone.
    Grossman D; Baba CF; Kaller S; Biggs MA; Raifman S; Gurazada T; Rafie S; Averbach S; Meckstroth KR; Micks EA; Berry E; Raine-Bennett TR; Creinin MD
    Obstet Gynecol; 2021 Apr; 137(4):613-622. PubMed ID: 33706339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.